{"id":"W3132666517","doi":"10.1016/j.cgh.2021.02.025","title":"Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":240,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Ustekinumab; Medicine; Adverse effect; Placebo; Internal medicine; Crohn's disease; Randomized controlled trial; Maintenance therapy; Dosing; Randomization; Clinical trial; Surgery; Disease; Chemotherapy; Adalimumab; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005083769,0.0009267225,0.00155771,0.0003404564,0.0005353668,0.001154711,0.000841068,0.001589705,0.003465106],"category_scores_gemma":[0.003405554,0.0003523073,0.001798659,0.0003549205,0.0007681802,0.001249188,0.0008385018,0.002971466,0.000435517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006743592,"about_ca_system_score_gemma":0.0005066627,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000476173,"about_ca_topic_score_gemma":0.0009736476,"domain_scores_codex":[0.998143,0.001155826,0.0001263307,0.0001814155,0.0001639184,0.0002294224],"domain_scores_gemma":[0.9979085,0.0004838361,0.0007573987,0.0002213538,0.0001033378,0.0005255689],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9284054,0.006583859,0.01446762,0.001453284,0.004248563,0.00009964847,0.0001826257,0.0009873698,0.001712992,0.0005616281,0.003108956,0.03818799],"study_design_scores_gemma":[0.7434788,0.1576552,0.07916138,0.0005590784,0.007841134,0.0003310416,0.00018537,0.001840076,0.002005503,0.0009586383,0.005887439,0.00009633695],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752078,0.01650005,0.0004308628,0.0009932501,0.0003378902,0.001097354,0.00127426,0.00006509493,0.004093538],"genre_scores_gemma":[0.992596,0.002080898,0.0005251142,0.0009566584,0.0003709411,0.001005231,0.001244303,0.00001026615,0.001210655],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005083769,"threshold_uncertainty_score":0.02688587,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02035173540616127,"score_gpt":0.3085475369863828,"score_spread":0.2881958015802216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}